TY - CHAP M1 - Book, Section TI - Papulosquamous Conditions A1 - Usatine, Richard P. A1 - Sabella, Camille A1 - Smith, Mindy Ann A1 - Mayeaux, E.J. A1 - Chumley, Heidi S. A1 - Appachi, Elumalai PY - 2015 T2 - The Color Atlas of Pediatrics AB - References1Foley P, Zuo Y, Plunkett A, Merlin K, Marks R. The frequency of common skin conditions in preschool-aged children in Australia: seborrheic dermatitis and pityriasis capitis (cradle cap). Arch Dermatol. 2003;139(3):318–322.12622623[PubMed: ]2Breunig Jde A, de Almeida HL Jr, Duquia RP, Souza PR, Staub HL. Scalp seborrheic dermatitis: prevalence and associated factors in male adolescents. Int J Dermatol. 2012;51(1):46–49.22182377[PubMed: ]3Schechtman RC, Midgley G, Hay RJ. HIV disease and Malassezia yeasts: a quantitative study of patients presenting with seborrhoeic dermatitis. Br J Dermatol. 1995;133(5):694–698.8555018[PubMed: ]4Gaitanis G, Magiatis P, Hantschke M, Bassukas ID, Velegraki A. The Malassezia genus in skin and systemic diseases. Clin Microbiol Rev. 2012;25(1):106–141.22232373[PubMed: ]5Naldi L, Alfredo Rebora A. Seborrheic dermatitis. N Engl J Med. 2009;360;4:387–396.6Hay RJ. Malassezia, dandruff and seborrheic dermatitis: an overview. Br J Dermatol. 2011;165 (2):2–8.21919896[PubMed: ]7Danby FW, Maddin WS, Margesson LJ, Rosenthal D.A randomized, double-blind, placebo-controlled trial of ketoconazole 2% shampoo versus selenium sulfide 2.5% shampoo in the treatment of moderate to severe dandruff. J Am Acad Dermatol. 1993;29:1008–1012.8245236[PubMed: ]8Pierard-Franchimont C. A multicenter randomized trial of ketoconazole 2% and zinc pyrithione 1% shampoos in severe dandruff and seborrheic dermatitis. Skin Pharmacol Appl Skin Physiol. 2002;15(6):434–441.12476017[PubMed: ]9Aly R. Ciclopirox gel for seborrheic dermatitis of the scalp. Int J Dermatol. 2003;42(1):19–22.12895183[PubMed: ]10Lebwohl M, Plott T. Safety and efficacy of ciclopirox 1% shampoo for the treatment of seborrheic dermatitis of the scalp in the US population: results of a double-blind, vehicle-controlled trial. Int J Dermatol. 2004;43(1):17–20.15271196[PubMed: ]11Chosidow O, Maurette C, Dupuy P. Randomized, open-labeled, non-inferiority study between ciclopiroxolamine 1% cream and ketoconazole 2% foaming gel in mild to moderate facial seborrheic dermatitis. Dermatology. 2003;206:233–240.12673081[PubMed: ]12Pierard GE, Pierard-Franchimont C, Van CJ, Rurangirwa A, Hoppenbrouwers ML, Schrooten P. Ketoconazole 2% emulsion in the treatment of seborrheic dermatitis. Int J Dermatol. 1991;30:806–809.1836780[PubMed: ]13Katsambas A, Antoniou C, Frangouli E, Avgerinou G, Michailidis D, Stratigos J. A double-blind trial of treatment of seborrheic dermatitis with 2% ketoconazole cream compared with 1% hydrocortisone cream. Br J Dermatol. 1989;121:353–357.2529893[PubMed: ]14Dupuy P, Maurette C, Amoric JC, Chosidow O. Randomized, placebo-controlled, double-blind study on clinical efficacy of ciclopiroxolamine 1% cream in facial seborrheic dermatitis. Br J Dermatol. 2001;135:1033–1037.15Vena GA, Micali G, Santoianni P, Cassano N, Peruzzi E. Oral terbinafine in the treatment of multi-site seborrheic dermatitis: a multicenter, double-blind placebo-controlled study. Int J Immunopathol Pharmacol. 2005;18:745–753.16388724[PubMed: ]16Scaparro E, Quadri G, Virno G, Orifici C, Milani M. Evaluation of the efficacy and tolerability of oral terbinafine (Daskil) in patients with seborrheic dermatitis. A multicentre, randomized, investigator-blinded, placebo-controlled trial. Br J Dermatol. 2001;135(4):854–857.17Firooz A, Solhpour A, Gorouhi F, et al. Pimecrolimus cream, 1%, vs hydrocortisone acetate cream, 1%, in the treatment of facial seborrheic dermatitis: a randomized, investigator-blind, clinical trial. Arch Dermatol. 2006;142:1066–1067.16924062[PubMed: ]18Freeman SH. Efficacy, cutaneous tolerance and cosmetic acceptability of desonide 0.05% lotion (Desowen) versus vehicle in the short-term treatment of facial atopic or seborrheic dermatitis. Australas J Dermatol. 2002;43(3):186–189.12121395[PubMed: ]19Rigopoulos D, Ioannides D, Kalogeromitros D, Gregoriou S, Katsambas A. Pimecrolimus cream 1% vs. betamethasone 17-valerate 0.1% cream in the treatment of seborrheic dermatitis. A randomized open-label clinical trial. Br ... SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/03/29 UR - accesspediatrics.mhmedical.com/content.aspx?aid=1114876064 ER -